Consistent with our observations, it had been reported that in metastatic pancreatic cancer, PGRN induced increased fibroblast infiltration and increased fibrotic matrix formation, resulting in decreased CD8+ T cell infiltration and resistance to the αPD-1 antibody therapy. Here, CD8A is linked to familial pancreatic carcinoma.